PKSFX
Price
$54.71
Change
-$0.29 (-0.53%)
Updated
Jun 2 closing price
Net Assets
2.1B
VSCIX
Price
$109.21
Change
-$0.13 (-0.12%)
Updated
Jun 2 closing price
Net Assets
139.54B
Interact to see
Advertisement

PKSFX vs VSCIX

Header iconPKSFX vs VSCIX Comparison
Open Charts PKSFX vs VSCIXBanner chart's image
Virtus KAR Small-Cap Core I
Price$54.71
Change-$0.29 (-0.53%)
VolumeN/A
Net Assets2.1B
Vanguard Small Cap Index I
Price$109.21
Change-$0.13 (-0.12%)
VolumeN/A
Net Assets139.54B
PKSFX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PKSFX vs. VSCIX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PKSFX is a Buy and VSCIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 140B vs. PKSFX (2.1B). VSCIX pays higher dividends than PKSFX: VSCIX (1.49) vs PKSFX (0.21). PKSFX was incepted earlier than VSCIX: PKSFX (29 years) vs VSCIX (28 years). PKSFX (1.01) is less costly to investors than VSCIX (0.04). VSCIX is a more actively managed with annual turnover of: 13.00 vs. PKSFX (5.00). PKSFX has a lower initial minimum investment than VSCIX: PKSFX (100000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 3.08 vs. PKSFX (2.64). VSCIX return over 5 years is better than : 55.43 vs. PKSFX (34.93).
PKSFXVSCIXPKSFX / VSCIX
Total Expense Ratio1.010.042,525%
Annual Report Gross Expense Ratio1.010.042,525%
Fund Existence29 years28 years-
Gain YTD-3.424-4.95569%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets2.1B140B2%
Annual Yield % from dividends0.211.4914%
Returns for 1 year2.643.0886%
Returns for 3 years28.5317.64162%
Returns for 5 years34.9355.4363%
Returns for 10 years111.8693.03120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVVE1.490.27
+22.13%
Nuvve Holding Corp
KROS14.660.51
+3.60%
Keros Therapeutics
PRPH0.37N/A
+1.14%
ProPhase Labs
BMRN57.05-1.02
-1.76%
BioMarin Pharmaceutical
CNMD55.38-1.37
-2.41%
CONMED Corp